Cargando…
Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis: Improvement with Target Combination
Although the clinical application of new drugs has been shown to be effective in slowing disease progression and improving the quality of life in patients with pulmonary fibrosis, the damaged lung tissue does not recover with these drugs. Thus, there is an urgent need to establish regenerative thera...
Autores principales: | Chuang, Hong-Meng, Shih, Tina Emily, Lu, Kang-Yun, Tsai, Sheng-Feng, Harn, Horng-Jyh, Ho, Li-Ing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299195/ https://www.ncbi.nlm.nih.gov/pubmed/29991279 http://dx.doi.org/10.1177/0963689718787501 |
Ejemplares similares
-
Recent Findings on Cell-Based Therapies for COVID19-Related Pulmonary Fibrosis
por: Chuang, Hong-Meng, et al.
Publicado: (2021) -
The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
por: Chuang, Hong-Meng, et al.
Publicado: (2019) -
Non-Canonical Regulation of Type I Collagen through Promoter Binding of SOX2 and Its Contribution to Ameliorating Pulmonary Fibrosis by Butylidenephthalide
por: Chuang, Hong-Meng, et al.
Publicado: (2018) -
The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration
por: Chuang, Hong-Meng, et al.
Publicado: (2016) -
Clinical Application Potential of Small Molecules that Induce Brown Adipose Tissue Thermogenesis by Improving Fat Metabolism
por: Lu, Kang-Yun, et al.
Publicado: (2020)